Dow Down 1.29% Nasdaq Down 3.25%

Athersys, Inc. (ATHX)

-NasdaqCM
1.23 Down 0.01(0.81%) Feb 5, 4:00PM EST
Prev Close:1.24
Open:1.23
Bid:1.08 x 1000
Ask:1.46 x 2000
1y Target Est:4.25
Beta:-1.18587
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:1.20 - 1.26
52wk Range:0.90 - 3.43
Volume:200,414
Avg Vol (3m):413,448
Market Cap:102.50M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ATHX

Comparison

Symbol% ChgMkt Cap
ATHXDown 0.81%102.50M
OSIRUp 5.45%220.15M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):65.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.34
Quarterly EPS Est (Dec-15) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback